Clinical features at transformation in adult T-cell leukemia–lymphoma with smoldering and chronic types

被引:0
作者
Hiroaki Taniguchi
Yoshitaka Imaizumi
Yumi Takasaki
Jun Nakashima
Takeharu Kato
Hidehiro Itonaga
Shinya Sato
Yasushi Sawayama
Koji Ando
Hiroo Hasegawa
Tomoko Hata
Yukiyoshi Moriuchi
Kunihiro Tsukasaki
Yasushi Miyazaki
机构
[1] Sasebo City General Hospital,Department of Hematology
[2] Nagasaki University Hospital,Department of Hematology
[3] Saint Francis Hospital,Department of Hematology
[4] Nagasaki University Hospital,Department of Laboratory Medicine
[5] Saitama Medical University,Department of Hematology, International Medical Center
来源
International Journal of Hematology | 2019年 / 109卷
关键词
Adult T-cell leukemia–lymphoma (ATL); Transformation; Smoldering; Chronic;
D O I
暂无
中图分类号
学科分类号
摘要
Watchful waiting (WW) is among the treatment options indicated for patients with indolent adult T-cell leukemia–lymphoma (ATL). However, we previously showed that the long-term prognosis of patients with smoldering and chronic ATL is often worse than expected, with many undergoing transformation to aggressive ATL. To identify clinical features associated with transformation of smoldering/chronic ATL, we retrospectively analyzed the clinical features of 44 patients (14 smoldering and 30 chronic) who experienced transformation during WW. An elevated lactate dehydrogenase (LDH) value was most often observed (n = 30) at the time of transformation, especially in the chronic type (n = 24). Major organ involvement, lymphadenopathy, and hypercalcemia were shown to be associated with transformation in transformed patients without elevated LDH. The median overall survival time after transformation was only 7.8 months, and the prognosis was poor after transformation in those fulfilling the criteria of acute type, similar to that of de novo aggressive ATL. Laboratory data, such as LDH, and clinical signs including exacerbation of performance status, skin lesions, and lymphadenopathy should all be monitored during WW to ensure appropriate timing of chemotherapy initiation. Identification of optimal predictive markers for transformation and new therapeutic options is warranted to improve outcomes in indolent ATL.
引用
收藏
页码:402 / 408
页数:6
相关论文
共 88 条
[61]  
Hino R(undefined)undefined undefined undefined undefined-undefined
[62]  
Hama K(undefined)undefined undefined undefined undefined-undefined
[63]  
Ohmori S(undefined)undefined undefined undefined undefined-undefined
[64]  
Fueki H(undefined)undefined undefined undefined undefined-undefined
[65]  
Yamada S(undefined)undefined undefined undefined undefined-undefined
[66]  
Bittencourt AL(undefined)undefined undefined undefined undefined-undefined
[67]  
da Gracas Vieria M(undefined)undefined undefined undefined undefined-undefined
[68]  
Brites CR(undefined)undefined undefined undefined undefined-undefined
[69]  
Farre L(undefined)undefined undefined undefined undefined-undefined
[70]  
Barbosa HS(undefined)undefined undefined undefined undefined-undefined